The proposed "End Organ and Genomic Harvesting Act" aims to prohibit certain practices related to human organ transplants and genetic analysis technologies. Specifically, the bill prohibits health benefit plans from covering organ transplants or post-transplant care if the procedures are performed in countries known for forced organ harvesting, such as the People's Republic of China. Additionally, it restricts the use of genetic sequencers and operational software produced by foreign adversaries in medical and research facilities within Arkansas, mandating that any genetic sequencing data be stored outside of these countries and ensuring compliance through annual certifications to the Attorney General and the Department of Health.

The bill also establishes definitions for key terms, such as "forced organ harvesting" and "health benefit plan," and outlines penalties for violations, including fines for entities that fail to comply with the regulations. The Insurance Commissioner is granted the authority to designate additional countries involved in forced organ harvesting and to develop rules for the implementation of these provisions. Overall, the act seeks to enhance the ethical standards surrounding organ transplants and genetic research in Arkansas.